Category:

Health

Latest

Scientists agree Covid is airborne, want overhaul of ventilation systems

Cleaner indoor air won’t just fight the pandemic, it will minimize the risk of catching flu and other respiratory infections that cost the U.S. more than $50 billion a year, researchers said in a study in the journal ‘Science’ on Friday. Avoiding these germs and their associated sickness and productivity losses would, therefore, offset the cost of upgrading ventilation and filtration in buildings.
The study’s authors, comprising 39 scientists from 14 countries, are demanding universal recognition that infections can be prevented by improving indoor ventilation systems.

read more

$10 trillion lost globally due to COVID-19 pandemic and lockdowns:WHO Report  

A report by the panel cited estimates that more than $10 trillion has been lost globally because of the COVID-19 pandemic and lockdowns to control its spread that has closed businesses and confined people to their homes. “Every effort to integrate beforehand health and finance will largely pay itself,” said Mario Monti ,former Italian prime minister chairs the WHO’s Pan-European Commission on Health and Sustainable Development .
It has recommended the G20 establish a Global Health Board which would work to prevent future pandemics by identifying risks, setting global benchmarks for preparedness, and promoting investment in health infrastructure.

read more

269 doctors died due to COVID in second wave of pandemic: Indian Medical Association

Speaking to ANI, IMA president Dr JA Jayalal said, “Mortality among doctors is high as we are exposed to high viral load. We attain hundreds of patients whose infections are high. Also, many people come with symptomatic COVID, even their attendants are positive. So, doctors are exposed to this more.” “The working hours of doctors have been extended because the number of patients has increased. Keeping these all leads to high mortality among doctors. But this is not the case with doctors only, several deaths are occurring among the common public too,” added Dr Jayalal.
State-wise data by IMA shows 22 doctors died due to COVID-19 in Andhra Pradesh, 19 in Telangana, 14 each in Maharashtra and West Bengal, and 11 fatalities were reported in Tamil Nadu. It added that 10 doctors also died in Odisha, eight in Karnataka, and five in Madhya Pradesh.

read more

India second largest insurtech market in APAC: S&P Report

”India is the second largest insurance technology market in Asia-Pacific. India has at least 66 insurtech companies and accounted for 35 per cent of the USD 3.66 billion in insurtech-focused venture capital invested in the APAC region. ”Insurance technology investors are attracted to India since it is one of the fastest-growing insurance markets in the world,” S&P Global Market Intelligence fintech analyst Sampath Sharma Nariyanuri said.

read more

Govt releases Rs 5,968 crore to 15 states under Jal Jeevan Mission

Of the central funds allocated under the Jal Jeevan Mission, 93 percent is to be utilized on developing water supply infrastructure, 5 per cent on support activities and 2 percent on water quality monitoring and surveillance.

The JJM dashboard also shows the ‘sensor-based IoT pilot project going on different villages which shows the status of daily water supply in terms of quantity, quality and regularity. In these pilots, one can see the quality of water and per capita supply on daily basis. This dashboard can be accessed at: https://ejalshakti.gov.in/jjmreport/JJMIndia.aspx.

read more

Less than 2 pc population affected by COVID in India, 98 pc still vulnerable: Govt

The government said that of the total population in India, 1.8 per cent has been affected by COVID-19 so far and 98 per cent of the population is still susceptible or vulnerable to the infection.

The government said a continued decline has been noted in active cases in the last 15 days. From 17.13 per cent of the total caseload reported on May 3, it has reduced to 13.3 per cent, it added.

read more

Covaxin phase II/III clinical trials for 2-18 age group to begin in 10-12 days: Govt

“Covaxin has been approved by the Drugs Controller General of India (DCGI), for Phase II/III clinical trials in the age group of 2 to 18 years. I have been told that trials will begin in the next 10-12 days,” Paul said during a press conference.
Hours after Delhi Chief Minister Arvind Kejriwal stated that the new COVID variant detected in Singapore is “deadly for children” and may bring in third wave of the disease in the country, Paul reassured that children will not get serious COVID-19 infection, adding that the situation is being closely monitored and reports referring to the variant are being examined.

read more